Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025

Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung, Renal, Musculoskeletal, Heart), End User, Region - Global Forecast to 2025

The global primary cells market is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. Market growth is driven by the rising prevalence of cancer, the rapid growth in the biotechnology & biopharmaceutical industries, growing focus on R&D, recent developments in stem cell therapy, the increasing demand for monoclonal antibodies, and advantages of primary human cells over cell lines are the major factors driving the growth of the primary cells market.

“The human primary cells accounted for the highest growth rate in the primary cells market, by origin, during the forecast period”
Based on origin, the primary cells market is segmented into human and animal primary cells. The human primary cells segment accounted for the highest growth rate in the primary cells market in 2019. The increasing funding for the R&D of regenerative therapies, the rising incidence of cancer, and the growing application areas of human stem cells are the major factors driving the growth of this segment.

“Hepatocytes segment accounted for the highest CAGR”
Based on type, the primary cells market is segmented into hematopoietic cells, dermatocytes, gastrointestinal cells, hepatocytes, lung cells, renal cells, heart cells, musculoskeletal cells, and other primary cells. In 2019, the hepatocytes segment accounted for the highest growth rate. Increasing research funding by key pharma players, increasing incidence of liver cancer & pediatric liver diseases across the globe, and the emergence of new companies dedicated to liver therapeutics research are the major factors driving the growth of this segment.

“Life science research companies segment accounted for the highest CAGR”
Based on end-users, the primary cells market is segmented into life science research companies and research institutes. In 2019, the life science research companies segment accounted for the highest growth rate. This can be attributed to the increasing investments of companies in cell-based research, high adoption of primary cells in cell-based experiments, increasing cancer research in life science research companies, and the increasing number of R&D facilities globally.
“Asia Pacific: The fastest-growing region primary cells market”
The global primary cells market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific region is projected to grow at the highest CAGR during the forecast period in 2019. The growth in this region can be attributed to the increasing research activities in Asian countries, the availability of funding for research, a growing number of biobanks & research centers, rising prevalence of cancer, and recent developments in tissue engineering & stem cell therapy.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
• By Designation: C-level - 30%, D-level - 20%, and Others - 50%
• By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, and Rest of the World – 12%
Lits of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (US)
• Merck KGaA (Germany)
• Lonza (Switzerland)
• Cell Biologics, Inc. (US)
• PromoCell GmbH (Germany)
• HemaCare Corporation (US)
• ZenBio, Inc. (US)
• STEMCELL Technologies, Inc. (Canada)
• Corning Incorporated (US)
• AllCells (US)
• American Type Culture Collection (US)
• Axol Bioscience Ltd. (UK)
• iXCells Biotechnologies (US)
• Neuromics (US)
• StemExpress (US)
• BioIVT (US)
• ScienCell Research Laboratories, Inc. (US)
• PPA Research Group, Inc. (US)
• Creative Bioarray (US)
• BPS Bioscience, Inc. (US)
• Epithelix Sàrl (Switzerland)
• ReachBio LLC (US)
• AcceGen (US)
• Sekisui XenoTech, LLC (US)
• Biopredic International (France).

Research Coverage:
This report provides a detailed picture of the global primary cells market. It aims at estimating the size and future growth potential of the market across different segments, such as origin, type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall primary cells market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • REPORT COMPARISON WITH THE JULY 2018 EDITION
      • SUMMARY OF CHANGES
      • LIMITATIONS OF THE CURRENT EDITION
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PRIMARY CELLS MARKET OVERVIEW
    • PRIMARY CELLS MARKET, BY ORIGIN, 2020 VS. 2025 (USD MILLION)
    • PRIMARY CELLS MARKET SHARE, BY END USER, 2020 VS. 2025 (USD MILLION)
    • PRIMARY CELLS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table PROJECTED INCREASE IN THE NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
        • Table RESEARCH FUNDING FOR NATIONAL CANCER INSTITUTE, 2015 VS. 2017 (USD MILLION)
        • Table GROWTH IN THE NUMBER OF PERSONALIZED MEDICATIONS, 2008-2016
      • RESTRAINTS
      • OPPORTUNITIES
    • COVID-19 IMPACT ON THE PRIMARY CELLS MARKET
    • PRICING ANALYSIS
      • Table PRICE OF PRIMARY CELLS (2020)
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS OF THE PRIMARY CELLS MARKET
  • PRIMARY CELLS MARKET, BY ORIGIN
    • INTRODUCTION
      • Table PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
    • HUMAN PRIMARY CELLS
      • INCREASING PREVALENCE OF CANCER TO SUPPORT MARKET GROWTH
        • Table HUMAN PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • ANIMAL PRIMARY CELLS
      • RISING INVESTMENTS IN ANIMAL CELL RESEARCH TO PROPEL THE MARKET GROWTH
        • Table ANIMAL PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • PRIMARY CELLS MARKET, BY TYPE
    • INTRODUCTION
      • Table PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • HEMATOPOIETIC CELLS
      • INCREASING CANCER RESEARCH & FUNDING TO PROPEL THE MARKET GROWTH
        • Table HEMATOPOIETIC CELLS, BY TYPE
        • Table HEMATOPOIETIC CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: HEMATOPOIETIC CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • DERMATOCYTES
      • RISING PREVALENCE OF MELANOMA IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
        • Table DERMATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: DERMATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • GASTROINTESTINAL CELLS
      • INCREASING INCIDENCE OF STOMACH CANCER TO BOLSTER MARKET GROWTH
        • Table GASTROINTESTINAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: PRIMARY GASTROINTESTINAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • HEPATOCYTES
      • Table GLOBAL LIVER DISORDER INCIDENCE
      • Table HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • Table HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table EUROPE: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table ASIA PACIFIC: HEPATOCYTES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • CRYOPRESERVED HEPATOCYTES
        • Table CRYOPRESERVED HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
      • FRESH HEPATOCYTES
        • Table FRESH HEPATOCYTES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • LUNG CELLS
      • INCREASING RATE OF LUNG CANCER & COPD TO DRIVE THE DEMAND FOR LUNG CELLS
        • Table LUNG CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: LUNG CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • RENAL CELLS
      • LACK OF AVAILABILITY OF EFFECTIVE RENAL THERAPIES TO PROPEL MARKET GROWTH
        • Table RENAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: RENAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • HEART CELLS
      • HIGH INCIDENCE OF CARDIOVASCULAR DISEASES IS SUPPORTING THE GROWTH OF THIS SEGMENT
        • Table HEART CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: HEART CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • MUSCULOSKELETAL CELLS
      • RISING INCIDENCE OF MUSCULOSKELETAL DISORDERS TO PROPEL MARKET GROWTH
        • Table MUSCULOSKELETAL CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
        • Table NORTH AMERICA: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table EUROPE: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
        • Table ASIA PACIFIC: MUSCULOSKELETAL CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • OTHER PRIMARY CELLS
      • Table OTHER PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table EUROPE: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table ASIA PACIFIC: OTHER PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • PRIMARY CELLS MARKET, BY END USER
    • INTRODUCTION
      • Table PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • LIFE SCIENCE RESEARCH COMPANIES
      • INCREASING INVESTMENTS IN CELL-BASED RESEARCH TO DRIVE THE MARKET GROWTH
        • Table PRIMARY CELLS MARKET FOR LIFE SCIENCE RESEARCH COMPANIES, BY REGION, 2018-2025 (USD MILLION)
    • RESEARCH INSTITUTES
      • INCREASING GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER ARE DRIVING MARKET GROWTH
        • Table PRIMARY CELLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • PRIMARY CELLS MARKET, BY REGION
    • INTRODUCTION
      • Table PRIMARY CELLS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table NORTH AMERICA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • US
        • Table US: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table US: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table US: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table US: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • CANADA
        • Table CANADA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table CANADA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table CANADA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • EUROPE
      • Table EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table EUROPE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
      • Table EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table EUROPE: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table EUROPE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • UK
        • Table UK: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table UK: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table UK: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • GERMANY
        • Table GERMANY: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table GERMANY: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table GERMANY: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • FRANCE
        • Table FRANCE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table FRANCE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table FRANCE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • ITALY
        • Table ITALY: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table ITALY: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table ITALY: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table ROE: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table ROE: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: PRIMARY CELLS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
      • Table APAC: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
      • Table APAC: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table APAC: HEPATOCYTES, BY TYPE, 2018-2025 (USD MILLION)
      • Table APAC: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • CHINA
        • Table CHINA: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table CHINA: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table CHINA: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • JAPAN
        • Table JAPAN: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table JAPAN: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table JAPAN: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
        • Table ROAPAC: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        • Table ROAPAC: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: PRIMARY CELLS MARKET, BY ORIGIN, 2018-2025 (USD MILLION)
      • Table ROW: PRIMARY CELLS MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table ROW: HEPATOCYTES MARKET, BY TYPE, 2018-2025 (USD MILLION)
      • Table ROW: PRIMARY CELLS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES
        • Table PRODUCT LAUNCHES
      • AGREEMENTS
        • Table AGREEMENTS
      • EXPANSIONS
        • Table EXPANSIONS
      • PARTNERSHIPS
        • Table PARTNERSHIPS
      • ACQUISITIONS
        • Table ACQUISITIONS
  • COMPANY EVALUATION MATRIX AND COMPANY PROFILES
    • COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
      • VENDOR EXCLUSION CRITERIA
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2019)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPANY PROFILES
      • THERMO FISHER SCIENTIFIC, INC.
      • MERCK KGAA
      • LONZA
      • PROMOCELL GMBH
      • CORNING INCORPORATED
      • AMERICAN TYPE CULTURE COLLECTION (ATCC)
      • CELL BIOLOGICS, INC.
      • HEMACARE CORPORATION (A CHARLES RIVER LABORATORIES, INC. COMPANY)
      • ZENBIO, INC.
      • STEM CELL TECHNOLOGIES, INC.
      • ALLCELLS
      • AXOL BIOSCIENCE LTD.
      • IXCELLS BIOTECHNOLOGIES
      • NEUROMICS
      • STEMEXPRESS
      • BIOIVT
      • SCIENCELL RESEARCH LABORATORIES, INC.
      • SEKISUI XENOTECH, LLC
      • PPA RESEARCH GROUP, INC.
      • CREATIVE BIOARRAY
      • BPS BIOSCIENCE, INC.
      • EPITHELIX SÀRL
      • REACHBIO LLC
      • ACCEGEN
      • BIOPREDIC INTERNATIONAL
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook